COMPARISON OF CLINICAL AND BIOCHEMICAL VARIABLES BETWEEN PATIENTS ON TWICE A WEEK DIALYSIS REGIME HAVING DIFFERENT RESIDUAL RENAL FUNCTION – A JACK IN THE BOX

Authors

  • A AFZAL Department of nephrology, services institute of medical sciences, services hospital Lahore-Pakistan.
  • Z RAFIQUE Department of nephrology, services institute of medical sciences, services hospital Lahore-Pakistan.
  • A GULZAR Department of nephrology, services institute of medical sciences, services hospital Lahore-Pakistan
  • MA RAUF Department of nephrology, services institute of medical sciences, services hospital Lahore-Pakistan
  • A TALAL Department of nephrology, services institute of medical sciences, services hospital Lahore-Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2022i1.129

Keywords:

Renal failure, , Quality of life, SF-12 QoL, , chronic kidney disease, dialysis

Abstract

In resource limiting counties, it is a general observation that patients with chronic kidney disease have undergone twice a week dialysis even though they need thrice a week dialysis regime. This not only increases the burden on hospital emergencies but also affects the quality of life of the patients. The current analysis aims to assess the quality of life, biochemical variables, and adverse events in patients on twice a week dialysis having renal urea clearance less than 2 mL/min/1.73 m2 (Kr < 2 mL/min/1.73 m2) as compared to those undergoing twice weekly dialysis having renal urea clearance Kr greater than 2 mL/min/1.73 m2. This investigation was carried out at the Department of Nephrology, in Services Hospital Lahore. The study involved a total of sixty participants. They were then split into two separate groups. Thirty participants in Group A were on twice a week dialysis and had Kr > 2 mL/min/1.73 m2, whereas in Group B, participants with the same age and sex were also on twice a week dialysis regime but had Kr < 2 mL/min/1.73 m2. According to the 2006 Kidney Disease Outcome Quality Initiative (KDOQI) Clinical Practice Guidelines, individuals with renal urea clearance (Kr) less than 2 mL/min/1.73 m2 should undergo thrice-weekly hemodialysis. Therefore, Group B was not following the recommended weekly dialysis schedule. The primary objective of the study was to assess the difference in biochemical variables and the last sixmonth emergency visits and the second goal was to determine the quality of life by using the Sf-12 QoL questionnaire. The trial involved a total of sixty participants receiving twice-weekly dialysis. Males made up 59% of the study's participants. The participants' average age was 42.18 ± 18.10 years. Group A had a mean age of 38.9 ± 17.6 years, while group B had a mean age of 41.2 ± 14.9 years. Systolic blood pressure was significantly higher in group B compared to group A (p=0.04). The biochemical examination revealed that group B had significantly lower levels of albumin (p=0.001) and higher levels of urea and calcium (p=0.01 and 0.046, respectively) than group A. It was discovered that group B had significantly more hospital visits than group A (p=0.003). Using the SF-12 to measure quality of life, there was no discernible difference between the groups. The patients were on twice a week dialysis despite their renal urea clearance of less than 2 mL/min/1.73 m2 having compromised clinical and biochemical parameters. In addition, they also had greater number of emergency visits. Thus, we can conclude that thrice a weekly dialysis is a recommended regime for effected patients having Kr less than2 mL/min/1.73 m2. 

Downloads

Download data is not yet available.

References

Abdu, A., Lawrence, A. B., Shuaibu, A. T., and Sani, T. (2019). Hemodialysis outcome at Rasheed Shekoni Hospital. Nigerian Journal of Basic and Clinical Sciences 16, 42. Abdu, A., Mahmood, I. M., Audi, K. Y., and Umar, M. S. (2020). Clinical characteristics and outcomes of hemodialysis in a new center in Northern Nigeria. Nigerian Medical Journal: Journal of the Nigeria Medical Association 61, 340.

Chen, W., Laiho, S., Vaittinen, O., Halonen, L., Ortiz, F., Forsblom, C., Groop, P., Lehto, M., and Metsälä, M. (2016). Biochemical pathways of breath ammonia (NH3) generation in patients with end-stage renal disease undergoing hemodialysis. Journal of breath research 10, 036011. Colombo, G., Reggiani, F., Astori, E., Altomare, A., Finazzi, S., Garavaglia, M. L., Angelini, C., Milzani, A., Badalamenti, S., and DalleDonne, I. (2019). Advanced oxidation protein products in nondiabetic end stage renal disease patients on maintenance haemodialysis. Free Radical Research 53, 1114-1124. Gordon, E. J., Feinglass, J., Carney, P., Ramirez, D., Olivero, M., O'Connor, K., MacLean, J., Brucker, J., and Caicedo, J. C. (2015). An interactive, bilingual, culturally targeted website about living kidney donation and transplantation for hispanics: development and formative evaluation. JMIR research protocols 4, e3838. GULZAR, A., RAFIQUE, Z., AFZAL, A., IMRAN, S., ISRAR, A., and NASIM, A. (2022). ASSESSMENT OF FACTORS ASSOCIATED WITH THE REFUSAL OF RECOMMENDED THRICE A WEEK DIALYSIS IN CKD PATIENTS: REALITY VERSUS RECOMMENDATIONS. Biological and Clinical Sciences Research Journal 2022. Hagar, Y., Albers, D., Pivovarov, R., Chase, H., Dukic, V., and Elhadad, N. (2014). Survival analysis with electronic health record data: Experiments with chronic kidney disease. Statistical Analysis and Data Mining: The ASA Data Science Journal 7, 385-403. Jagodzińska, M., Zimmer-Nowicka, J., and Nowicki, M. (2011). Three months of regular gum chewing neither alleviates xerostomia nor reduces overhydration in chronic hemodialysis patients. journal of renal nutrition 21, 410417. Kassim-Lakha, S. (2012). The Engagement of Philanthropy. In "Urolithiasis", pp. 907-913. Springer. Koppe, L., Fouque, D., and Soulage, C. O. (2018). The role of gut microbiota and diet on uremic retention solutes production in the context of chronic kidney disease. Toxins 10, 155. Lazarus, J. M., Hampers, C. L., and Merrill, J. P. (1974). Hypertension in chronic renal failure: Treatment with hemodialysis and nephrectomy. Archives of Internal Medicine 133, 1059-1066. Lee, Y.-J., Rhee, C. M., and Kalantar-Zadeh, K. (2018). Residual kidney function in twiceweekly hemodialysis: irreplaceable contribution to dialysis adequacy. Annals of translational medicine 6. Lesaffer, G., De Smet, R., Lameire, N., Dhondt, A., Duym, P., and Vanholder, R. (2000). Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane. Nephrology Dialysis Transplantation 15, 50-57. Maake, P. M. (2017). Pre-operative patient education for patients undergoing kidney transplant as viewed by nephrology nurses. Naghavi, S., Mehrolhassani, M. H., Nakhaee, N., and Yazdi-Feyzabadi, V. (2019). Effective factors in non-compliance with therapeutic orders of specialists in outpatient clinics in Iran: a qualitative study. BMC health services research 19, 1-16. Ndinya, F. O. (2016). Haemodialysis vascular access function in dialysis patients at the Kenyatta National Hospital, University of Nairobi. Özkan, İ., and Taylan, S. (2022). Diet and fluid restriction experiences of patients on hemodialysis: a meta-synthesis study. Revista de nefrología, diálisis y transplante 42, 22-40. Rota-Musoll, L., Brigidi, S., Molina-Robles, E., Oriol-Vila, E., Perez-Oller, L., and SubiranaCasacuberta, M. (2021). An intersectional gender analysis in kidney transplantation: women who donate a kidney. BMC nephrology 22, 1-10. Seki, M., Nakayama, M., Sakoh, T., Yoshitomi, R., Fukui, A., Katafuchi, E., Tsuda, S., Nakano, T., Tsuruya, K., and Kitazono, T. (2019). Blood urea nitrogen is independently associated with renal outcomes in Japanese patients with stage 3–5 chronic kidney disease: a prospective observational study. BMC nephrology 20, 1-10. Shah, K. K., Murtagh, F. E., McGeechan, K., Crail, S., Burns, A., Tran, A. D., and Morton, R. L. (2019). Health-related quality of life and wellbeing in people over 75 years of age with endstage kidney disease managed with dialysis or comprehensive conservative care: a crosssectional study in the UK and Australia. BMJ open 9, e027776. Siddique, A. B., Krebs, M., Alvarez, S., Greenspan, I., Patel, A., Kinsolving, J., and Koizumi, N. (2019). Mobile apps for the care management of chronic kidney and end-stage renal diseases: systematic search in app stores and evaluation. JMIR mHealth and uHealth 7, e12604. Sussman, E. J., Singh, B., Clegg, D., Palmer, B. F., and Kalantar-Zadeh, K. (2020). Let them eat healthy: can emerging potassium binders help overcome dietary potassium restrictions in chronic kidney disease? Journal of Renal Nutrition 30, 475-483. Tonelli, M., and Dickinson, J. A. (2020). Early detection of CKD: implications for lowincome, middle-income, and high-income countries. Journal of the American Society of Nephrology 31, 1931-1940. van Haalen, H., Jackson, J., Spinowitz, B., Milligan, G., and Moon, R. (2020). Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: Analysis of multinational real-world data. BMC nephrology 21, 1-15. Vanholder, R., Gryp, T., and Glorieux, G. (2018). Urea and chronic kidney disease: the comeback of the century?(in uraemia research). Nephrology Dialysis Transplantation 33, 4-12. Ye, M., Hu, K., Jin, J., Wu, D., Hu, P., and He, Q. (2018). The association between time-mean serum uric acid levels and the incidence of chronic kidney disease in the general population: a retrospective study. BMC nephrology 19, 1-10.

Downloads

Published

2022-11-06

How to Cite

AFZAL, A., RAFIQUE, Z., GULZAR, A., RAUF, M., & TALAL, A. (2022). COMPARISON OF CLINICAL AND BIOCHEMICAL VARIABLES BETWEEN PATIENTS ON TWICE A WEEK DIALYSIS REGIME HAVING DIFFERENT RESIDUAL RENAL FUNCTION – A JACK IN THE BOX . Biological and Clinical Sciences Research Journal, 2022(1). https://doi.org/10.54112/bcsrj.v2022i1.129

Issue

Section

Original Research Articles